PATENT CLAIM ANALYSIS

Application Number: 16258606
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "374000"]

Abstract:
The present invention is directed to methods of treating and/or ameliorating portal hypertension by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

Claim (Index 18):
The method of  claim 1 , wherein the mammal is a human patient with portal hypertension and the therapeutically effective amount of the thromboxane A 2  receptor antagonist or a pharmaceutically acceptable salt thereof has an action selected from the group consisting of blockade of thromboxane-mediated signaling in the thromboxane receptor resulting in an anti-fibrotic effect in cirrhotic disease, interruption of the signaling pathway to lower portal pressure, thereby reducing hepatic vascular resistance and managing the symptoms of portal hypertension and combinations of any of the foregoing.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14715143', '15592727', '16240368', '15608507', '16004666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8349521335763641
- 35 USC 102 Novelty (BERT): 0.5774093876082981
- Combined Prediction Score: 0.8091978589795574
- Mean Citation Score: 481.51012
- Max Citation Score: 512.1572
- Similarity Product: 367.0186879959345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test